Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?
Tasnim Abdalla, Michelle A. Lowes, Nirmal Kaur, Robert G. Micheletti, A. Hillary Steinhart, Afsáneh Alavi
Topics & Concepts
Hidradenitis suppurativaMedicinePharmacotherapyTumor necrosis factor alphaDrugTumor necrosis factor αAdalimumabTherapeutic drug monitoringDermatologyPharmacologyInternal medicineIntensive care medicineOncologyDiseaseHidradenitis Suppurativa and TreatmentsColorectal and Anal CarcinomasMicroscopic Colitis